
PMC:7335494 / 23601-23884
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T92 | 65-83 | Disease | denotes | metabolic syndrome | http://purl.obolibrary.org/obo/MONDO_0004955 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T243 | 62-64 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
T244 | 190-191 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T239 | 106-128 | Chemical | denotes | galactooligosaccharide | http://purl.obolibrary.org/obo/CHEBI_24151 |
T240 | 129-136 | Chemical | denotes | mixture | http://purl.obolibrary.org/obo/CHEBI_60004 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T111 | 0-283 | Sentence | denotes | Double-blind, crossover, placebo-controlled, randomized study 45 metabolic syndrome patients risk factors galactooligosaccharide mixture intervention to increase dietary fibre content, with a 4-wk wash-out period between interventions ↓ faecal calprotectin, CRP Vulevic et al. (2013) |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32640331-23303873-30720799 | 278-282 | 23303873 | denotes | 2013 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32640331-23303873-30720799 | 278-282 | 23303873 | denotes | 2013 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2012 | 254-257 | GO:0007631 | denotes | in, |
T2013 | 262-272 | CHEBI:5086;CHEBI:5086 | denotes | Vulevic et |
T2014 | 273-276 | CHEBI:35218;CHEBI:35218 | denotes | al. |